Skip to main content
Fig. 5 | Acta Neuropathologica Communications

Fig. 5

From: Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis

Fig. 5

Reduction of efnA5 levels does not alter glial gene expression in symptomatic mice. Gene expression of several glial genes was quantified in the lumbar spinal cord of SOD1WT, SOD1G93A EfnA5+/+ and SOD1G93A EfnA5+/− mice. a Aif, b Gfap, and c Vimentin levels were unaltered in SOD1G93A EfnA5+/− mice. Data represents mean ± SEM (N = 6–7), and different conditions were compared with a one-way ANOVA with Tukey’s multiple comparisons test: * P < 0.05; ** P < 0.01; *** P < 0.001 as compared with SOD1WT mice

Back to article page